Crescendo Biologics

Crescendo Biologics

Crescendo Biologics

A rich internal pipeline of truly differentiated, multifunctional Humabody VH therapeutics with a focus on oncology
Raised
$70M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$70,000,000
Venture capital (Series B) - 2018
Quan Capital Andera Partners
Team Size
1–10
Employees
$70,000,000 Venture capital (Series B)
PE HUB , FinSMEs

Crescendo Biologics rakes in $70 mln Series B

Messaging